During the past decade, Metropolitan General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metropolitan General Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Apyx Medical" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Isofol Medical AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan General Hospital" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan General Hospital" are "Urinary Bladder Neoplasms" (2 trials), "Breast Cancer" (1 trials), "Colorectal Neoplasm" (1 trials), "Early Breast Cancer" (1 trials) and "First Line Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Metropolitan General Hospital" in a lesser frequency.

Most popular intervention types in "Metropolitan General Hospital" are "Drug" (7 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Cetrelimab" (2 trials), "Cisplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan General Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Metropolitan General Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Metropolitan General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan General Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".